JPS6341502A - Complex polysaccharide and production thereof - Google Patents

Complex polysaccharide and production thereof

Info

Publication number
JPS6341502A
JPS6341502A JP18623986A JP18623986A JPS6341502A JP S6341502 A JPS6341502 A JP S6341502A JP 18623986 A JP18623986 A JP 18623986A JP 18623986 A JP18623986 A JP 18623986A JP S6341502 A JPS6341502 A JP S6341502A
Authority
JP
Japan
Prior art keywords
compound
formula
hydrogen atom
group
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP18623986A
Other languages
Japanese (ja)
Other versions
JPH0717684B2 (en
Inventor
Tomoya Ogawa
智也 小川
Mamoru Sugimoto
守 杉本
Toru Kitajima
徹 北島
Yasuo Nukada
額田 恭郎
Kaan Sadozai Karido
カリド・カーン・サドザイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN Institute of Physical and Chemical Research
Original Assignee
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN Institute of Physical and Chemical Research filed Critical RIKEN Institute of Physical and Chemical Research
Priority to JP18623986A priority Critical patent/JPH0717684B2/en
Publication of JPS6341502A publication Critical patent/JPS6341502A/en
Publication of JPH0717684B2 publication Critical patent/JPH0717684B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

PURPOSE:To obtain a novel complex polysaccharide useful as an intermediate for synthesizing glycoprotein of cell cortex or as a reagent for elucidating biological significance and function of the glycoprotein, by reacting specific two compounds in the presence of a glycosylation catalyst. CONSTITUTION:A compound shown by formula I (Ac is acetyl; R is lower alkyl) is reacted with a compound shown by formula II (Bn is benzyl; Phth is phthaloyl) in the presence of a glycosylation catalyst (e.g. TiCl4), SnCl4, molecular sieve 4A, etc.) in a solvent preferably dichloroethane, benzene, etc., -25-60 deg.C, and if necessary, deacetylated, debenzylated, dephthaloylated and acetylated to give a novel compound shown by formula III (R is H or lower alkyl; R<1> is H or acetyl; R<2> is H or benzyl; R<3> is H; R<4> is acetyl or R<3> and F<4> form phthaloyl; Y is H, etc.).

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は新規な複合多糖およびその製造法に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to a novel complex polysaccharide and a method for producing the same.

〔発明の背景〕[Background of the invention]

細胞表層の糖蛋白質は、糖鎖を外側に配向して存在し、
生物情報マーカーとして機能している。
Glycoproteins on the cell surface exist with sugar chains oriented outward,
It functions as a biological information marker.

糖蛋白質の糖鎖の中で、蛋白質部分とN−グリコシド結
合している糖鎖が最も複雑な構造を有しており、現在ま
でに種々の分校構造が知られている。
Among the sugar chains of glycoproteins, sugar chains that are N-glycoside bonded to protein moieties have the most complex structure, and various branch structures are known to date.

本発明者らは、3重分技をもつ複合型Il!鎖の6糖単
位の合成に成功している。(小川ら、カーボハイドレー
ト・リサーチ(Carbohydrate Res、)
、 93(1981)CI)。本発明者らは更に、■に
示すような2重分技を有する複合型糖鎖の9vM単位構
造(1)の合成を目的として研究を進め、その部分構造
化合物の合成に成功した(特開昭6(151702号公
報参照)。
The present inventors have developed a complex type Il! with triple division technique! The hexasaccharide unit of the chain has been successfully synthesized. (Ogawa et al., Carbohydrate Res)
, 93 (1981) CI). The present inventors further conducted research with the aim of synthesizing the 9vM unit structure (1) of a complex type sugar chain having a double division technique as shown in Showa 6 (see Publication No. 151702).

本発明者らは更に子牛の血液凝固因子■のAsn−37
6及び因子■のAsn−261に結合している、Iに類
似する■に示すような11糖単位構造(IT)の全合成
を目的として研究を行い、本発明を完成するに至った。
The present inventors further discovered that Asn-37 of calf blood coagulation factor
We conducted research aimed at the total synthesis of the 11-saccharide unit structure (IT) shown in (3), which is similar to I, and which is bonded to Asn-261 of factor (6) and factor (2), leading to the completion of the present invention.

■ 式1.TIにおいて、SAはシアル酸残基、Ga1lは
ガラクトース残基、GNはグルコサミン残基、Mはマン
ノース残基を示す。
■ Formula 1. In TI, SA represents a sialic acid residue, Ga1l represents a galactose residue, GN represents a glucosamine residue, and M represents a mannose residue.

〔発明の構成〕[Structure of the invention]

本発明は下記の一般式で表される複合多糖およびその製
造法を提供するものである。
The present invention provides a complex polysaccharide represented by the following general formula and a method for producing the same.

式中Rは水素原子または低級アルキル基、R1は水素原
子またはアセチル基、R2は水素原子またはベンジル基
、R3は水素原子、R4はアセチル基、またはR″とR
4が共同してフタロイル基を示し、Yは水素原子または (式中、RおよびR1は前記定義のとおりである)を示
す。
In the formula, R is a hydrogen atom or a lower alkyl group, R1 is a hydrogen atom or an acetyl group, R2 is a hydrogen atom or a benzyl group, R3 is a hydrogen atom, R4 is an acetyl group, or R'' and R
4 together represent a phthaloyl group, and Y represents a hydrogen atom or (in the formula, R and R1 are as defined above).

上記化合物は式(1): (式中、Acはアセチル基、Rは低級アルキル基を示す
。)で表される化合物と、式(2):(式中Bnはベン
ジル基、Ph thはフタロイル基を示す) で表される化合物をグリコジル化触媒存在下に反応させ
、必要により脱アセチル化、脱ベンジル化、脱フタロイ
ル化およびアセチル化することにより製造することがで
きる。
The above compound is a compound represented by the formula (1): (wherein, Ac is an acetyl group and R is a lower alkyl group) and a compound represented by the formula (2): (wherein, Bn is a benzyl group, and Ph th is a phthaloyl group). It can be produced by reacting a compound represented by (representing a group) in the presence of a glycosylation catalyst, and optionally deacetylating, debenzylating, defthaloylating and acetylating.

まず本発明方法の出発物質化合物(1)は次のように合
成することができる。
First, the starting material compound (1) for the method of the present invention can be synthesized as follows.

次式(101)  : で示される化合物(101)を、メタノール、エタノー
ル等の溶媒中、CH30Na、 K 2 CO2、Na
、CO2、トリエチルアミン等の塩基触媒存在下に、−
5℃〜60℃で30分〜24時間反応させて脱アセチル
化し、化合物(102)を得る。
The compound (101) represented by the following formula (101) is mixed with CH30Na, K2CO2, Na in a solvent such as methanol or ethanol.
, CO2, in the presence of a base catalyst such as triethylamine, -
Deacetylation is performed by reacting at 5°C to 60°C for 30 minutes to 24 hours to obtain compound (102).

化合物(102)をDMF、アセトン、DMF−アセト
ン等の溶媒中、トルエンスルホン酸(TsOH)、Zn
Cj!z 、BF3. EtzO等の触媒存在下、ジメ
トキシプロパンと、0℃〜80℃で30分〜24時間反
応させて4,6−ジーO−イソプロピリデン体を得、こ
れをさらにピリジン、トリエチルアミン、ジメチルアミ
ノピリジン等の塩基触媒存在下、無水酢酸と、0°C〜
80℃で15分〜24時間反応させてアセチル体(10
3)を得る。
Compound (102) was mixed with toluenesulfonic acid (TsOH), Zn in a solvent such as DMF, acetone, and DMF-acetone.
Cj! z, BF3. In the presence of a catalyst such as EtzO, dimethoxypropane is reacted at 0°C to 80°C for 30 minutes to 24 hours to obtain a 4,6-di-O-isopropylidene compound, which is further reacted with pyridine, triethylamine, dimethylaminopyridine, etc. In the presence of a base catalyst, acetic anhydride and 0°C ~
The acetyl form (10
3) is obtained.

化合物(103)を、メタノール、エタノール、または
これらと水の混合溶媒中、Ac0H1CF 3 COO
H(T F A )等により0℃〜80℃で20分〜2
4時間処理してイソプロピリデン基を脱離し、ジオール
(104)を得る。
Compound (103) was dissolved in Ac0H1CF 3 COO in methanol, ethanol, or a mixed solvent of these and water.
20 minutes to 2 at 0℃ to 80℃ using H(TFA) etc.
The isopropylidene group is removed by treatment for 4 hours to obtain diol (104).

ジオール(104)に、モレキュラーシーブ4A、Hg
Brz−Hg (CN)z、八go S OzCF 3
、へg−シリケート、八g2CO3、AgCAO4等の
グリコジル化触媒存在下、式(120)  : で表される化合物を反応させて4糖性化合物(105)
(α体)および(106) (β体)を得る。溶媒はジ
ク0ロエタン、ジクロロメタン、トルエン、ニトロメタ
ン、ベンゼン、CH3CN 、 D M F等が適当で
あり、−15℃〜60℃、30分〜24時間で反応は十
分に進行する。
Diol (104), molecular sieve 4A, Hg
Brz-Hg (CN)z, 8go S OzCF 3
, heg-silicate, 8g2CO3, AgCAO4, etc. in the presence of a glycosylation catalyst, the compound represented by formula (120): is reacted to form a tetrasaccharide compound (105)
(α form) and (106) (β form) are obtained. Suitable solvents include dichloroethane, dichloromethane, toluene, nitromethane, benzene, CH3CN, DMF, etc., and the reaction proceeds satisfactorily at -15°C to 60°C for 30 minutes to 24 hours.

化合物(105)を常法によりアセチル化して化合物(
107)を得る。この化合物(107)をAcOH−H
20XMeOH−HzO,ベンゼン−EtOHHg0等
の溶媒中、PdCIlz、Pd  CI 2、(Cb 
Hs) :+ P RhCA!(ウィルキンソン錯体)
等の触媒存在下、室温〜80℃で1時間〜24時間処理
して脱アリル化して化合物(108)を得る。
Compound (105) was acetylated by a conventional method to obtain compound (
107) is obtained. This compound (107) was converted into AcOH-H
PdCIlz, PdCI2, (Cb
Hs) :+P RhCA! (Wilkinson complex)
Compound (108) is obtained by treatment at room temperature to 80° C. for 1 hour to 24 hours in the presence of a catalyst such as .

化合物(108)をMeOH−AcOH,MeOH。Compound (108) in MeOH-AcOH, MeOH.

MeOHHgO等の溶媒中、10%Pd−C,5%Pd
  C,Pd (OH)z、pto2等の触媒存在下、
室温〜60°Cで1時間〜24時間、水素接触還元して
ベンジル基を脱離したのち、常法によりアセチル化し、
化合物(109)を得る。
10% Pd-C, 5% Pd in a solvent such as MeOHHgO
In the presence of a catalyst such as C, Pd (OH)z, pto2,
After removing the benzyl group by hydrogen catalytic reduction at room temperature to 60°C for 1 to 24 hours, acetylation was performed by a conventional method.
Compound (109) is obtained.

化合物(109)を、DM F 、CHtCt2 z、
CA CHzCHzCA等に熔解し、NHzNHz・A
cOH存在下、20℃〜80℃で5分〜3時間処理して
選択的脱アセチル化を行い化合物(110)を得る。
Compound (109), DMF, CHtCt2z,
Melts into CA CHzCHzCA etc., NHzNHz・A
Selective deacetylation is performed by treatment at 20° C. to 80° C. for 5 minutes to 3 hours in the presence of cOH to obtain compound (110).

化合物(110)をCHzCA z 、CI CHzC
I■zc6、トルエン、ベンゼン等に溶解し、DBtJ
 (ジアザビシクロウンデカン)、Na1(等の触媒存
在下、トリクロロアセトニトリルと、−20℃〜40°
Cで30分〜6時間反応させることにより、出発物質(
11を得る。
Compound (110) in CHzCA z , CI CHzC
Izc6, dissolved in toluene, benzene, etc., DBtJ
(diazabicycloundecane), trichloroacetonitrile in the presence of a catalyst such as Na1 (-20°C to 40°C)
By reacting at C for 30 minutes to 6 hours, the starting material (
Get 11.

もう一方の出発物質(2)は、特開昭60−51702
号公報記載の方法に従って合成することができる。
The other starting material (2) is JP-A-60-51702
It can be synthesized according to the method described in the publication.

かくして得られた化合物(1)と化合物(2)をグリコ
ジル化触媒存在下に反応させて、7!J!性化合物(3
)とIIIJi性化合物(7)を得る。グリコジル化触
媒としてはBF、・Et2o、TMS )リフレート、
TiCj!、 、5nC14、モレキュラーシーブ4A
Compound (1) and compound (2) thus obtained were reacted in the presence of a glycosylation catalyst, and 7! J! sexual compound (3
) and IIIJi compound (7) are obtained. Glycosylation catalysts include BF, ・Et2o, TMS) reflate,
TiCj! , , 5nC14, molecular sieve 4A
.

モレキュラーシーブAW−300などが使用できる。ン
容媒はジクロロエタン、ジクロロメタン、クロロホルム
、トルエン、ベンゼン、ニトロメタンなどが適当であり
、温度は一25℃〜60℃が適当である。
Molecular sieve AW-300 etc. can be used. Suitable solvents include dichloroethane, dichloromethane, chloroform, toluene, benzene, nitromethane, etc., and the temperature is suitably between -25°C and 60°C.

化合物(3)または(7)を、ピリジン、コリジン、ピ
ア コリン等の溶媒中、Lil触媒存在下、60°C〜還流
温度で1時間〜12時間処理してエステルを加水分解し
、それぞれ化合物(4)または(8)を得る。
Compound (3) or (7) is treated in a solvent such as pyridine, collidine, or piacolin in the presence of a Lil catalyst at a temperature of 60°C to reflux for 1 to 12 hours to hydrolyze the ester, resulting in compound (4), respectively. ) or (8) is obtained.

次に化合物(4)または(8)を、EtOH、MeOH
等の溶媒中、抱水ヒドラジン、n−ブチルアミン、メチ
ルアミン等のアルキルアミン類などの触媒存在下、50
°C〜還流温度で1時間〜24時間処理してフタロイル
基およびアセチル基を脱離し、次いでMeOH、EtO
H1水等の溶媒中、無水酢酸を加え、0℃〜室温で1時
間〜24時間処理してアミノ基をアセチル化し、それぞ
れ化合物(5)または(9)を得る。
Next, compound (4) or (8) was added to EtOH, MeOH
in the presence of a catalyst such as hydrazine hydrate, n-butylamine, alkyl amines such as methylamine, etc.
Treatment at °C to reflux temperature for 1 to 24 hours removes phthaloyl and acetyl groups, followed by MeOH, EtO
Acetic anhydride is added in a solvent such as H1 water, and the mixture is treated at 0° C. to room temperature for 1 hour to 24 hours to acetylate the amino group to obtain compound (5) or (9), respectively.

化合物(5)または(9)を常法により、たとえば10
%Pd−C存在下、水素接触還元してヘンシル基を脱離
し、それぞれ目的化合物(6)または00)を得る。
Compound (5) or (9) is prepared by a conventional method, for example, 10
% Pd-C, the Hensyl group is removed by hydrogen catalytic reduction to obtain the target compound (6) or 00), respectively.

上記工程の一例を次のスキーム1.2.3および4に示
す。
An example of the above process is shown in the following schemes 1.2.3 and 4.

〉=≠ = 特開口UG3−41502  (13)AcNeuα2
−6GaIlβ1−4 G j! cNAcβ八cNe
へα2−6Ga1β 1→4 G j! cNAcβス
キーム1.2.3および4において←は〇−アセチル基
を、−は○〜ベンジル基をそれぞれ示す。
〉=≠ = Special opening UG3-41502 (13) AcNeuα2
-6Gallβ1-4 G j! cNAcβ8cNe
to α2−6Ga1β 1→4 G j! In cNAcβ schemes 1.2.3 and 4, ← represents a 〇-acetyl group, and - represents a ○ to benzyl group, respectively.

上記工程により得られる化合物(102) 、(103
)、(104) 、(105) 、(106) 、(1
07) 、(108)、(109) 、(110) 、
ftl、(3)、(4)、(5)、(6)、(7)、(
8)、(9)および00)は新規化合物である。
Compounds (102) and (103) obtained by the above steps
), (104), (105), (106), (1
07), (108), (109), (110),
ftl, (3), (4), (5), (6), (7), (
8), (9) and 00) are new compounds.

〔有用性〕〔Usefulness〕

本発明により得られる上記の新規化合物は、細胞表層糖
蛋白質を合成する際の中間体として、又、細胞表層糖蛋
白質の生物学的意義や機能を解明する際の試薬としての
有用性を有するものである。
The above novel compounds obtained by the present invention are useful as intermediates in the synthesis of cell surface glycoproteins and as reagents in elucidating the biological significance and functions of cell surface glycoproteins. It is.

以下実施例により本発明を更に詳細に説明するが、これ
らは何ら本発明の範囲を制限するものではない。
The present invention will be explained in more detail with reference to Examples below, but these are not intended to limit the scope of the present invention in any way.

なお、以下の実施例および参考例において、特に明記し
ない限り、旋光度〔α〕、の測定はCH(1,中25℃
で行った。
In addition, in the following examples and reference examples, unless otherwise specified, the optical rotation [α] is measured at 25°C in CH (1,
I went there.

参考例1 化合物(101)  650mg (0,59mmo7
りをメタノールに溶かしNa OCHsを加え室温で一
昼夜攪拌する。反応液をアンバーリスト15で中和し、
ろ過して後減圧濃縮する。化合物(102)  435
mg(86%)を得る。
Reference Example 1 Compound (101) 650mg (0.59mmo7
Dissolve the solution in methanol, add Na OCHs, and stir at room temperature overnight. Neutralize the reaction solution with Amberlyst 15,
Filter and concentrate under reduced pressure. Compound (102) 435
mg (86%).

〔化合物(102)の性質〕 Rf  O,31CIC1,a:MeOH3:INMR
(CD30D) 7.53−7.01  m、15B、
ベンジル×3゜6.17−5.69  m、 LH,−
CH=CH2゜1.93 131+、 S、 −NCO
CH3゜参考例2 化合物(102) 4.0 g (4,67mmo#)
をDMF80mj!に溶かし、0℃で攪拌しなからジメ
トキシプロパン5.Omj2TSOH−HzO160m
gを加え4時間攪拌する。反応液にトリエチルアミン1
0rr+j!を加え減圧濃縮する。残渣にピリジン80
mβ無水酢酸3 Q m Itを加え一昼夜攪拌する。
[Properties of compound (102)] Rf O,31CIC1,a:MeOH3:INMR
(CD30D) 7.53-7.01 m, 15B,
Benzyl x 3゜6.17-5.69 m, LH, -
CH=CH2゜1.93 131+, S, -NCO
CH3° Reference Example 2 Compound (102) 4.0 g (4,67mmo#)
DMF80mj! 5. Dissolve dimethoxypropane in water and stir at 0°C. Omj2TSOH-HzO160m
g and stirred for 4 hours. Triethylamine 1 in the reaction solution
0rr+j! Add and concentrate under reduced pressure. 80% pyridine in the residue
Add mβ acetic anhydride 3 Q m It and stir overnight.

反応液を濃縮し、残渣をシリカゲルカラム(400g>
に付し、トルエン−酢酸エチル−2:11%TEA含有
の溶媒系で溶出することにより化合物(103) 2;
 50 gを得る(収率50%)。
Concentrate the reaction solution and transfer the residue to a silica gel column (400g>
Compound (103) 2;
50 g (50% yield) are obtained.

〔化合物(103)の性質〕 17f  0.35 1−ルエンー酢酸エチル 1:3
元素分析 Cs5H6eNOz。として計算値 C,6
2,08,H,6,54,N、1.32実測値 C,6
1,84,H,6,6L  N、1.41〔α) o 
  +20.8”  C=0.93  CHC13参考
例3 化合物(103) 2.49 g (2,34mmoj
りをMeOH−AcOH1: 1 40mj!に溶かし
、70〜75℃で1時間45分攪拌する。反応液を減圧
濃縮し、残渣をシリカゲルカラム (SiOz  C−300200g  C)(C4!2
−MeOH20:1)で精製する。化合物(104)1
.48g(収率 61%)を得る。
[Properties of compound (103)] 17f 0.35 1-luene-ethyl acetate 1:3
Elemental analysis Cs5H6eNOz. Calculated value as C, 6
2,08,H,6,54,N,1.32 actual measurement value C,6
1,84,H,6,6L N, 1.41 [α) o
+20.8” C=0.93 CHC13 Reference Example 3 Compound (103) 2.49 g (2.34 mmoj
MeOH-AcOH1: 1 40mj! and stir at 70-75°C for 1 hour and 45 minutes. The reaction solution was concentrated under reduced pressure, and the residue was applied to a silica gel column (SiOz C-300200g C) (C4!2
-MeOH 20:1). Compound (104) 1
.. 48 g (yield 61%) are obtained.

〔化合物(104)の性質〕 Rf  Q、33  CHCes  YIeOH9: 
1元素分析 C7゜Hs lN OIbとして計算値 
C,?1.09. H,6,71,N、1.15実測値
 C,70,76、H,6,73,N、1.13〔α)
  n  ’   +20.Oo   C=1.26 
  C)I(1゜NMRCDIts   90MHz 
ppm  7MS7.48〜7.04.35H,m、ベ
ンジル基×76.08〜5.54  m、  LH,−
CH=CH2゜1.66   s   3HNAc 参考例4 活性化したM、3.4A、7.0gにh(CN)zl、
85 g、 HgBrz 1.32 gを加え化合物(
104)1.25 g (1,22mmo/) 、化合
物(120) 622.3mg  1.22 mmo7
!をジクロロエタン20mj!に溶かして加え、アルゴ
ン雰囲気下−15℃で攪拌する。反応液を室温にもどし
、8時間攪拌する。
[Properties of compound (104)] Rf Q, 33 CHCes YIeOH9:
Single element analysis C7゜Hs lN Calculated value as OIb
C,? 1.09. H, 6,71, N, 1.15 actual measurement value C, 70,76, H, 6,73, N, 1.13 [α)
n'+20. OoC=1.26
C) I(1゜NMRCDIts 90MHz
ppm 7MS7.48-7.04.35H,m, benzyl group x 76.08-5.54m, LH,-
CH=CH2゜1.66 s 3HNAc Reference Example 4 Activated M, 3.4A, 7.0g and h(CN)zl,
85 g and 1.32 g of HgBrz were added to form the compound (
104) 1.25 g (1.22 mmo/), Compound (120) 622.3 mg 1.22 mmo7
! 20mj of dichloroethane! and stirred at -15°C under an argon atmosphere. The reaction solution was returned to room temperature and stirred for 8 hours.

反応液を再び一15℃に冷却し、化合物(120)63
0mg(7mAジクロロエタン溶液として)注加し、室
温にもどして後−昼夜攪拌する。
The reaction solution was cooled again to -15°C, and compound (120) 63
0 mg (as a 7 mA dichloroethane solution) was added, the mixture was allowed to return to room temperature, and then stirred day and night.

反応液に一15℃でHg (CN)2616mg。Add 2616 mg of Hg (CN) to the reaction solution at -15°C.

HgBr、 440mg、化合物(120)  630
 g (4mlジクロロエタン溶液として)加える。−
昼夜攪拌した後ろ過し、ろ液を蒸留水、飽和重そう水で
洗浄したのちMgSO3で乾燥し、減圧濃縮する。残渣
をシリカゲルカラム(ワコーゲルC−300300g、
、CH2C7!2−7セト730 : 1) テ精製す
る。化合物(105)  (932mg、収率51%)
および化合物(106)  (673mg、収率37%
)を得る。
HgBr, 440mg, compound (120) 630
g (as a 4 ml dichloroethane solution). −
After stirring day and night, the mixture is filtered, and the filtrate is washed with distilled water and saturated deuterated water, dried over MgSO3, and concentrated under reduced pressure. The residue was filtered through a silica gel column (Wakogel C-300 300g,
, CH2C7!2-7Seto730: 1) Te purification. Compound (105) (932 mg, yield 51%)
and compound (106) (673 mg, yield 37%
).

〔化合物(105) (α体)の性質〕元素分析 C7
zHqzNzOsz ・2HzOとして計算値 C,5
6,39,H,6,05,N、1.83実測値 C,5
6,21,H,6,05,N、1.83NMR400M
Hz  CDCj23 7.38−7.17.15H,m、ベンジル基×35.
92−5.82 1H,m、 −CH=CH23,82
7,3)I、 s、 0CH32,587dd、 J=
4.4.12.6  H−3deq、 2.160゜2
.134.2.079.2.067、2.053.2.
048゜2.037.2.000. 1.89L、  
1.831  −COCI(3x〔化合物(106) 
(β体)の性質〕元素分析 C7□Hq z N 20
3□・H20として計算値 C,57,06,H,6,
12,N、1.85実測値 C,56,78,H,6,
24,N、1.87Rf  O,56CHCj!3Me
OH9: 1〔α)D’  +2.1”  C=1.0
2  CH(13NMR400MHz  CDC13 7,38−7,19,15H,m、ベンジル基×35.
91−5.81  LH,m、 −C)l−cI+23
.831,3H,s、 0CHz 2.476 dd、 J=12.8.4.9  H−3
deq、 2.156゜2.121.2.078.2.
078.2.054.2.034゜2.029.2.0
14.2.007.1.895.1.789 5−CO
岸bり10 参考例5 化合物(105)  1.07 g (0,715mm
o#)をピリジン20mj!、無水酢酸5mlに熔かし
、室温で一昼夜攪拌する。減圧濃縮し、残渣をシリカゲ
ルカラム(ワコーゲルC300700gCHCn3 :
MeOH30: 1)で精製する。化金物(107) 
 920mg (収率91%)を得る。
[Properties of compound (105) (α form)] Elemental analysis C7
zHzzNzOsz ・Calculated value assuming 2HzO C, 5
6,39,H, 6,05,N, 1.83 actual measurement value C,5
6,21,H, 6,05,N, 1.83NMR400M
Hz CDCj23 7.38-7.17.15H, m, benzyl group x 35.
92-5.82 1H,m, -CH=CH23,82
7,3) I, s, 0CH32,587dd, J=
4.4.12.6 H-3deq, 2.160°2
.. 134.2.079.2.067, 2.053.2.
048°2.037.2.000. 1.89L,
1.831 -COCI(3x [Compound (106)
(Properties of β-form) Elemental analysis C7□Hz z N 20
Calculated value as 3□・H20 C, 57, 06, H, 6,
12, N, 1.85 actual measurement C, 56, 78, H, 6,
24, N, 1.87Rf O, 56CHCj! 3Me
OH9: 1 [α)D'+2.1" C=1.0
2 CH (13NMR400MHz CDC13 7,38-7,19,15H,m, benzyl group x 35.
91-5.81 LH,m, -C)l-cI+23
.. 831,3H,s, 0CHz 2.476 dd, J=12.8.4.9 H-3
deq, 2.156°2.121.2.078.2.
078.2.054.2.034゜2.029.2.0
14.2.007.1.895.1.789 5-CO
Shore b10 Reference example 5 Compound (105) 1.07 g (0,715 mm
o#) with 20 mj of pyridine! , dissolved in 5 ml of acetic anhydride, and stirred at room temperature overnight. Concentrate under reduced pressure and transfer the residue to a silica gel column (Wakogel C300700gCHCn3:
Purify with MeOH30:1). Chemicals (107)
920 mg (91% yield) is obtained.

〔化合物(10T)の性質〕 Rf  O,50(CHCj!z  MeOH30: 
1)〔α) 、   −11,4° C=0.88  
CHCffi:+元素分析 C74Hq 4 N 20
 s a・1%H20計算値 C,56,73,H,6
,24,N、1.79実測値 C,56,74,H,6
,OL  N、1.71NMR400MHz  CD 
Cit 3  7MS7.38−7.17.15m、ベ
ンジル基×35.92−5.83 1FI  m  −
(!=CHz3.81L 3H,s、 OCH3,2,
551dd、 J=4.6;12.9  H−3deq 2.191.2.148.2.132.2.076、2
.057゜2.047.2.026.1.999.1.
957.1.894゜1.834 −COCHs x 
11 参考例6 化合物(107)  353mg (0,229mmo
β)をAcOHHzO(95: 5) 、15mAに溶
かし、塩化パラジウム48mg、酢酸ソーダ46mgを
加え、12時間攪拌する。反応液を減圧濃縮し、残渣を
酢酸エチルで希釈し、不溶物をセライトろ過する。
[Properties of compound (10T)] Rf O,50 (CHCj!z MeOH30:
1) [α) , -11,4° C=0.88
CHCffi:+Elemental analysis C74Hq 4 N 20
s a・1%H20 calculation value C, 56, 73, H, 6
,24,N,1.79 actual measurement value C,56,74,H,6
,OL N, 1.71NMR400MHz CD
Cit 3 7MS7.38-7.17.15m, benzyl group x 35.92-5.83 1FI m-
(!=CHz3.81L 3H,s, OCH3,2,
551dd, J=4.6;12.9 H-3deq 2.191.2.148.2.132.2.076, 2
.. 057°2.047.2.026.1.999.1.
957.1.894゜1.834 -COCHs x
11 Reference Example 6 Compound (107) 353 mg (0,229 mmo
β) was dissolved in AcOHHzO (95:5), 15 mA, 48 mg of palladium chloride and 46 mg of sodium acetate were added, and the mixture was stirred for 12 hours. The reaction solution was concentrated under reduced pressure, the residue was diluted with ethyl acetate, and insoluble matter was filtered through Celite.

ろ液を水洗、重そう水、食塩水で洗浄し、Mg5Oaで
乾燥する。減圧濃縮し、残渣をシリカゲルカラムで精製
する。
The filtrate is washed with water, dehydrated water, and brine, and dried over Mg5Oa. Concentrate under reduced pressure and purify the residue using a silica gel column.

CHCAa  :MeOH10: 1で溶離することに
より化合物(108)  121mg (35%)を得
た。
Elution with CHCAa:MeOH 10:1 gave 121 mg (35%) of compound (108).

〔化合物(107)の性質〕 Rf  O,35Men)(CHCj!a  1 : 
9元素分析 CHI HqoNzCL+x ・1 ’A
 HzOとして計算値 C,55,86,H,6,14
,N、1.84実測値 C,55,80,H,5,99
,N、1.75(α) D−19,8° C=0.61
  C)(Cβ3NMR400MHz  CD CI!
、s   7MS7.38−7.17 15)l、 m
、ベンジル基×33.814 3Hs  OCH32,
550dd、 J=4.4゜12.7  H−3deq 2.196.2.14L 2.124.2.073.2
.060゜2.051.2.C23,2,012,1,
960,1,894゜1.851 −COCH,x 1
1 参考例7 化合物(108)  391mg (0,26mmoj
りをメタノール20mn、八cOH2mj!に?容かし
10%Pd−C200mgを加え水素雰囲気下−昼夜接
触還元する。ろ過して後減圧濃縮し、残渣をピリジン5
ml、無水酢酸2.5 m Ilに熔かし、室温で3時
間攪拌する。
[Properties of compound (107)] Rf O,35Men)(CHCj!a 1 :
9 elemental analysis CHI HqoNzCL+x ・1'A
Calculated value as HzO C, 55, 86, H, 6, 14
, N, 1.84 actual measurement value C, 55,80, H, 5,99
, N, 1.75 (α) D-19,8° C=0.61
C) (Cβ3NMR400MHz CD CI!
, s 7MS7.38-7.17 15) l, m
, benzyl group x 33.814 3Hs OCH32,
550dd, J=4.4゜12.7 H-3deq 2.196.2.14L 2.124.2.073.2
.. 060°2.051.2. C23,2,012,1,
960,1,894°1.851 -COCH,x 1
1 Reference Example 7 Compound (108) 391mg (0.26mmoj
20mn of methanol, 8cOH2mj! To? Add 200 mg of 10% Pd-C to a vessel and catalytically reduce the mixture under a hydrogen atmosphere day and night. After filtering and concentrating under reduced pressure, the residue was diluted with pyridine 5
ml and 2.5 ml of acetic anhydride, and stirred at room temperature for 3 hours.

減圧濃縮し、残渣をシリカゲルカラム(ワコーゲルc−
30040g  ヘキサン−酢酸エチル1:20)で精
製し化合物(109)  284mgを得る(収率83
%)。
Concentrate under reduced pressure and transfer the residue to a silica gel column (Wakogel C-
30,040 g Hexane-ethyl acetate 1:20) to obtain 284 mg of compound (109) (yield: 83
%).

〔化合物(109)の性質〕 〔α) 、   −25,4° C=0.86  CH
(J!3Rf  O,174%メタノール含有CHC4
3元素分析 C5eHaoOa7Nz ・1’AHzO
として計算値 C,48,91,H,5,87,N、1
.97実測値 C,48,98,H,5,6B、  N
、1.94参考例8 化合物(109)  263mg (0,188mmo
7りをD M F 3.0 m j!に?容かし、ヒド
ラジニウムアセテ)18mgを加え、室温で40分攪拌
する。反応液を酢酸エチルで希釈し、水洗し、さらに飽
和食塩水で洗浄したのちMg5O,で乾燥する。減圧濃
縮し、残渣をシリカゲルカラムクロマトで精製する。
[Properties of compound (109)] [α), -25,4° C=0.86 CH
(J!3Rf O, CHC4 containing 174% methanol
Three element analysis C5eHaoOa7Nz ・1'AHzO
Calculated value as C, 48, 91, H, 5, 87, N, 1
.. 97 actual measurement value C, 48, 98, H, 5, 6B, N
, 1.94 Reference Example 8 Compound (109) 263 mg (0,188 mmo
D M F 3.0 m j! To? Add 18 mg of hydrazinium acetate to the mixture and stir at room temperature for 40 minutes. The reaction solution was diluted with ethyl acetate, washed with water, further washed with saturated saline, and then dried over Mg5O. Concentrate under reduced pressure and purify the residue using silica gel column chromatography.

シリカゲル(ワコーゲルc−30030g)CHCn3
 :MeOH24: 1で溶出し、出発原料化合物(1
09)  39mgを回収した。さらに溶出することに
より化合物(110)  215mg (収率91%)
を得た。
Silica gel (Wako gel c-30030g) CHCn3
:MeOH24:1, the starting material compound (1
09) 39 mg was recovered. Further elution yielded 215 mg of compound (110) (yield 91%)
I got it.

〔化合物(110)の性質〕 (α) n  −31,02° C=1.I  CHC
A 3元素分析 C,6H780,。Nz  HtOと
して計算値 C,48,9B、 H,5,87,N、2
.03実測値 C,49,02,H,5,70,N、1
.89Rf  O,43CHCj!:+  :MeOH
9: 1参考例9 化合物(110)  201mg (0,148mmo
A)をジクロロエタン3.0 m nに溶かし、トリク
ロロアセトニトリル0.3m1L DBU22.3μA
を加え、0°Cで30分、室温で1時間攪拌したのちシ
リカゲルカラム(ワコーゲル C−30020gEtO
Ac)で精製する。化合物(1) 188mg (収率
84.7%)を得た。
[Properties of compound (110)] (α) n −31,02° C=1. ICHC
A 3-element analysis C, 6H780,. Calculated value as Nz HtO C, 48, 9B, H, 5, 87, N, 2
.. 03 actual measurement value C, 49, 02, H, 5, 70, N, 1
.. 89Rf O, 43CHCj! :+ :MeOH
9: 1 Reference Example 9 Compound (110) 201 mg (0,148 mmo
Dissolve A) in 3.0 mn of dichloroethane, add 0.3 ml of trichloroacetonitrile, 22.3 μA of DBU
was added and stirred at 0°C for 30 minutes and at room temperature for 1 hour.
Purify with Ac). 188 mg (yield 84.7%) of compound (1) was obtained.

〔化合物(1)の性質〕 〔α)n   −19,3° (C=1.55  CH
Cjl!3)Rf  O,20EtOAc 元素分析 C65H7sO3bNsCflsとして計算
値 C,46,45,H,5,24,N、2.80実測
値 C,46,35,H,5,06,N、2.81実施
例1 活性化したモレキュラーシープAW−300300mg
に化合物(2189mg (0,064mmoIl )
、化合物(1) 74mg (0,049mmo6 )
をジクロロエタン7、0 m 12に溶かして加え、ア
ルゴン雰囲気下−10℃で攪拌しながらBF3・pt2
o6.5μ!(0,052mmoIl)を加え、2時間
攪拌した。
[Properties of compound (1)] [α)n −19,3° (C=1.55 CH
Cjl! 3) Rf O, 20EtOAc Elemental analysis Calculated value as C65H7sO3bNsCfls C, 46, 45, H, 5, 24, N, 2.80 Actual value C, 46, 35, H, 5, 06, N, 2.81 Example 1 Activated Molecular Sheep AW-300 300mg
compound (2189 mg (0,064 mmol))
, Compound (1) 74mg (0,049mmo6)
was dissolved in 7.0 m 12 of dichloroethane and added, and while stirring at -10°C under an argon atmosphere, BF3.pt2 was added.
o6.5μ! (0,052 mmol) was added and stirred for 2 hours.

反応液をセライトろ過し、ろ液を重そう水、蒸留水で洗
浄する。MgSO4で乾燥したのち、減圧濃縮し、残渣
をシリカゲルカラムで精製する。り0ロホルム−メタノ
ール25:1を用いて溶出し、化合物(3)63.7m
g (収率47.3%)を得た。
The reaction solution is filtered through Celite, and the filtrate is washed with deuterated water and distilled water. After drying with MgSO4, it is concentrated under reduced pressure, and the residue is purified with a silica gel column. Compound (3) was eluted with 25:1 roform-methanol (63.7 m
g (yield 47.3%) was obtained.

〔化合物(3)の性質〕 Rf  O,62CHCj!a  :MeOH9: 1
〔α)n   −12,2° (C・0.97  CH
C13)元素分析 Cl39HIS6053N4  ・
5H20として計算値 C,59,18,H,5,93
,N、1.99実測値 C,59,17,H,5,62
,N、2.33同じ溶媒で?容出することによりRf 
O,54(CHCn 3: CH30H)のフラクショ
ンを分離した(15mg)。このフラクションを薄層ク
ロマトグラフ(CCL  :アセトン 1:1)で精製
することにより化合物17)1.4mg (0,7%)
を得た。
[Properties of compound (3)] Rf O,62CHCj! a:MeOH9:1
[α)n −12,2° (C・0.97 CH
C13) Elemental analysis Cl39HIS6053N4 ・
Calculated value as 5H20 C, 59, 18, H, 5, 93
, N, 1.99 actual measurement value C, 59, 17, H, 5, 62
, N, 2.33 with the same solvent? By discharging Rf
A fraction of O,54 (CHCn 3: CH30H) was separated (15 mg). This fraction was purified by thin layer chromatography (CCL:acetone 1:1) to yield 1.4 mg (0.7%) of compound 17).
I got it.

〔化合物(7)の性質〕 Rf  O,12ccz、  :アセトン 1:1実施
例2 活性化したモレキュラーシーブAW−300500mg
に化合物(3119mg (0,0069mmoA)、
化合物(1113,5mg (0,009mmon )
をジクロロエタン2.5 m IIに溶かして加え、ア
ルゴン雰囲気下−10℃で攪拌しながらBF3・Et2
01μl(0,0081mmoA)を滴下し、1.5時
間攪拌する。化合物(IN 3.5mg (0,009
mmoj2) 、及びBFs・Et201.lj7! 
 (0,0081mmojlり  をくり返して添加し
、−10℃〜−20°Cで2時間攪拌する。反応液をセ
ライトろ過し、ろ液を、重そう水、蒸留水で洗浄し、M
gSO4で乾燥する。減圧濃縮し、残渣をシリカゲルカ
ラムで精製する。
[Properties of compound (7)] Rf O, 12 ccz, : Acetone 1:1 Example 2 Activated molecular sieve AW-300 500 mg
compound (3119mg (0,0069mmoA),
Compound (1113.5mg (0,009mmon)
was dissolved in 2.5 m of dichloroethane II and added, and while stirring at -10°C under an argon atmosphere, BF3/Et2 was added.
01 μl (0,0081 mmoA) was added dropwise and stirred for 1.5 hours. Compound (IN 3.5 mg (0,009
mmoj2), and BFs・Et201. lj7!
(Add 0,0081 mmojl repeatedly and stir at -10°C to -20°C for 2 hours. The reaction solution is filtered through Celite, and the filtrate is washed with deuterated water and distilled water.
Dry with gSO4. Concentrate under reduced pressure and purify the residue using a silica gel column.

粗収量43mg、さらに液体クロマトグラフGPL22
0カラム(CHC7!z)を用いて精製し、化合物(7
1B、 Omgを得た。(化合物(3)の回収9.3m
gを含めて収率55%)。
Crude yield: 43 mg, liquid chromatograph GPL22
0 column (CHC7!z) to obtain compound (7
1B, Omg was obtained. (Recovery of compound (3) 9.3 m
(yield 55% including g).

〔化合物(7)の性質〕 Rf  O,12(CC1,:アセトン、1:1)〔α
)n    −7,81° C=0.4  CHll 
[Properties of compound (7)] Rf O,12 (CC1,:acetone, 1:1) [α
)n −7,81° C=0.4 CHll
.

元素分析 C、、、H23□N b Oe e・H20
として計算値 C,57,32,H,5,77、N、2
.06実測値 C,57,03,H,5,75,N、1
.96実施例3 化合物f316. Omg、2.20X10−3mmo
j!、、Li1(180°で2時間減圧乾燥)5mgを
ピリジン0、1 m 7!に溶かし、4時間加熱還流す
る。反応液を酢酸エチルで希釈し、希塩酸、及び飽和食
塩水で洗浄する。無水硫酸マグネシウムで乾燥し、残渣
をシリカゲル(ワコーゲル C−3001g)カラムに
かけ12%MeOH含有CHCj!、で溶出精製し、化
合物(414,9mg (収率82%)を得た。
Elemental analysis C,,,H23□N b Oe e・H20
Calculated value as C, 57, 32, H, 5, 77, N, 2
.. 06 actual measurement value C, 57, 03, H, 5, 75, N, 1
.. 96 Example 3 Compound f316. Omg, 2.20X10-3mmo
j! ,, Li1 (dried under reduced pressure at 180° for 2 hours) 5 mg to pyridine 0,1 m 7! and heat under reflux for 4 hours. The reaction solution was diluted with ethyl acetate and washed with dilute hydrochloric acid and saturated brine. Dry over anhydrous magnesium sulfate, and apply the residue to a silica gel (Wakogel C-3001g) column containing 12% MeOH! , to obtain a compound (414.9 mg (yield: 82%)).

〔化合物(4)の性質〕 (α) o   −20,0° (MeOHXC=0.
27)Rf  O,1712%MeOH/ CHCj2
3実施例4 化合物(414,9mg (1,84X 10−’ m
moIl)をEtOHo、2mJに溶かし、抱水ヒドラ
ジン10μAを加え10時間加熱還流する。TLC上(
HPTLCnBuOH=EtOH=Hzo  4 : 
2 : 2  Rfo、56)  Iスポットになるこ
とを確認したのち、溶媒を減圧乾固する。残渣をMeO
Ho、1mI2に溶かし、氷冷攪拌下Acz05μlを
加え90分攪拌する。反応液を減圧ta縮し、残渣をセ
ファデックスLH−20’(0,8X 10cm  M
eOH)で精製し、脱フタロイル体4.0 mgを得る
[Properties of compound (4)] (α) o −20,0° (MeOHXC=0.
27) RfO, 1712%MeOH/CHCj2
3 Example 4 Compound (414.9 mg (1,84X 10-' m
mol) was dissolved in 2 mJ of EtOHo, 10 μA of hydrazine hydrate was added, and the mixture was heated under reflux for 10 hours. On TLC (
HPTLCnBuOH=EtOH=Hzo4:
2:2 Rfo, 56) After confirming that the I spot is formed, the solvent is dried under reduced pressure. Residue in MeO
Dissolve the solution in 1 mI2 of Ho, add 05 μl of Acz under ice-cooling and stirring, and stir for 90 minutes. The reaction solution was condensed under reduced pressure, and the residue was washed with Sephadex LH-20' (0.8X 10cm M
eOH) to obtain 4.0 mg of the defthaloyl product.

脱フタロイル体4.0mgをMeOH−H,O17:3
 0.2mnに溶かし、10%Pd−C3mgを加え接
触還元する。反応液をろ過し、母液を減圧濃縮する。
4.0 mg of dephthaloyl compound was added to MeOH-H, O17:3
Dissolve the solution to 0.2 mm, add 3 mg of 10% Pd-C, and perform catalytic reduction. The reaction solution is filtered, and the mother liquor is concentrated under reduced pressure.

残渣をセファデックスG  25(0,8X10cmH
z O)で精製する。化合物f611.4mg (54
%)を得る。
Sephadex G 25 (0.8 x 10 cmH)
z O). Compound f611.4mg (54
%).

〔化合物(6)の性質〕 Rf  O,18(nBuOH:EtOH: HzO4
: 2 : 2)〔α〕。 +7.7°(H2C、C=
0.07)NMR400MHz DzO60°、内積H
OD5.175  J=2.4  H−1aα、 4.
906  H−1d。
[Properties of compound (6)] Rf O,18(nBuOH:EtOH: HzO4
: 2 : 2) [α]. +7.7° (H2C, C=
0.07) NMR400MHz DzO60°, inner product H
OD5.175 J=2.4 H-1aα, 4.
906 H-1d.

4.726  H−1c、  4.685  J=8.
OH−1aβ。
4.726 H-1c, 4.685 J=8.
OH-1aβ.

4.600 H−1b、 H−1e、 2.663. 
J=4.4.12.2H−3geg、  2.011.
 2.019.2.039.2.057NHAc、  
 1.667   J=12.5   H−3gax。
4.600 H-1b, H-1e, 2.663.
J=4.4.12.2H-3geg, 2.011.
2.019.2.039.2.057NHAc,
1.667 J=12.5 H-3gax.

実施例5 化合物(7112mg (2,95X 10−3mmo
jり、Lil  5mg (180℃、減圧2時間乾燥
)をピリジン0.5 m i!に溶かし、8時間加熱還
流する。
Example 5 Compound (7112mg (2,95X 10-3mmo
5 mg of Lil (dried at 180°C for 2 hours under reduced pressure) and 0.5 m of pyridine. and heat under reflux for 8 hours.

反応液をクロロホルムで希釈し、希塩酸、飽和食塩水で
洗浄し、MgSO4で乾燥する。減圧濃縮し、残渣をシ
リカゲルカラム(c−3001g20%MeOH含有ク
ロロホルム)で精製する。化合物(817,0mg (
収率59%)を得る。
The reaction solution was diluted with chloroform, washed with dilute hydrochloric acid and saturated brine, and dried over MgSO4. Concentrate under reduced pressure and purify the residue with a silica gel column (c-3001g chloroform containing 20% MeOH). Compound (817.0mg (
yield of 59%).

〔化合物(8)の性質〕 〔α) n   −10,5° (CHsOH9C=0
.35)Rf  O,05(20χMeOH含有CHC
J3)実施例6    ′ 化合物(817mg1.733 X 10−” mmo
IlをEtOHQ、2m jl!に溶かし、N HzN
 H2・Hz○ 20p14を加え、3時間加熱還流す
る。
[Properties of compound (8)] [α) n −10,5° (CHsOH9C=0
.. 35) Rf O,05 (20χMeOH-containing CHC
J3) Example 6' Compound (817 mg1.733 X 10-'' mmo
Il to EtOHQ, 2m jl! Dissolved in N HzN
Add H2.Hz○ 20p14 and heat under reflux for 3 hours.

Rf  O,32nBuOH:EtOH: H2C4:
 2 : 2減圧濃縮し、残渣をMeOHO,1mff
に溶かし、Aczo  10μ2を加え水冷下2時間攪
拌する。
RfO,32nBuOH:EtOH: H2C4:
2: Concentrate under reduced pressure and dissolve the residue in MeOHO, 1mff
Add 10μ2 of Aczo and stir for 2 hours under water cooling.

Rf  O,39nBuOH:EtOH: H2C4:
 2 : 2減圧濃縮し、残渣をメタノールに溶かし、
セファデックスLH201,2cmX 18cm (メ
タノールで精製する。濃縮残渣を0.5 m Aのメタ
ノ−ルに溶かし、0.5N−NaOCH310μRを加
え室温で3時間攪拌する。反応液をアンバーリスト15
で中和したのちろ過、減圧乾固する。化合物(913,
2mgを得る。 (α) I、−7,06°(CH30
HC=0.16)化合物(9) 3.2mgをHzOI
mfに溶かし、10%Pd−C3mgを加え室温で2日
間接触還元する。ろ過し、減圧濃縮、残渣をセファデッ
クスG−25で精製し化合物QOI 1. Omgを得
た。
RfO,39nBuOH:EtOH: H2C4:
2: Concentrate under reduced pressure, dissolve the residue in methanol,
Sephadex LH201, 2cm x 18cm (Purify with methanol. Dissolve the concentrated residue in 0.5 mA methanol, add 10 μR of 0.5N-NaOCH, and stir at room temperature for 3 hours. The reaction solution is purified using Amberlyst 15.
After neutralizing with water, filter and dry under reduced pressure. Compound (913,
Get 2 mg. (α) I, -7,06° (CH30
HC=0.16) Compound (9) 3.2 mg at HzOI
mf, add 3 mg of 10% Pd-C, and perform catalytic reduction at room temperature for 2 days. Filtration, concentration under reduced pressure, and purification of the residue using Sephadex G-25 yielded compound QOI: 1. I got Omg.

収率26%(化合物(8)より) 〔化合物αωの性質〕 (α) D  −4,6° (H20C=0.05)N
MR400MH2D20 60” 、内積t−BuOD
5.185  H−1aα、 J=2.2.5.128
  H−1e。
Yield 26% (from compound (8)) [Properties of compound αω] (α) D −4,6° (H20C=0.05)N
MR400MH2D20 60”, inner product t-BuOD
5.185 H-1aα, J=2.2.5.128
H-1e.

4.925  H−1d、 4.753 H−1c、 
 4.695 H−1aαJ=7.4. 4.662 
 m H−1b  Hlh  H−1g。
4.925 H-1d, 4.753 H-1c,
4.695 H-1aαJ=7.4. 4.662
m H-1b Hlh H-1g.

Claims (2)

【特許請求の範囲】[Claims] (1)下記の一般式で示される複合多糖。 ▲数式、化学式、表等があります▼ 式中Rは水素原子または低級アルキル基、R^1は水素
原子またはアセチル基、R^2は水素原子またはベンジ
ル基、R^3は水素原子、R^4はアセチル基、または
R^3とR^4が共同してフタロイル基を示し、Yは水
素原子または ▲数式、化学式、表等があります▼ (式中、RおよびR^1は前記定義のとおりである) を示す。
(1) A complex polysaccharide represented by the general formula below. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ In the formula, R is a hydrogen atom or a lower alkyl group, R^1 is a hydrogen atom or an acetyl group, R^2 is a hydrogen atom or a benzyl group, R^3 is a hydrogen atom, R^ 4 is an acetyl group, or R^3 and R^4 jointly represent a phthaloyl group, and Y is a hydrogen atom or ▲A numerical formula, a chemical formula, a table, etc.▼ (In the formula, R and R^1 are as defined above. ).
(2)式: ▲数式、化学式、表等があります▼ (式中Acはアセチル基、Rは低級アルキル基を示す。 )で表される化合物と、式: ▲数式、化学式、表等があります▼ (式中Bnはベンジル基、Phthはフタロイル基を示
す) で表される化合物をグリコシル化触媒存在下に反応させ
、必要により脱アセチル化、脱ベンジル化、脱フタロイ
ル化およびアセチル化することを特徴とする下記の一般
式で表される複合多糖の製造法。 ▲数式、化学式、表等があります▼ 式中Rは水素原子または低級アルキル基、R^1は水素
原子またはアセチル基、R^2は水素原子またはベンジ
ル基、R^3は水素原子、R^4はアセチル基、または
R^3とR^4が共同してフタロイル基を示し、Yは水
素原子または ▲数式、化学式、表等があります▼ (式中、RおよびR^1は前記定義のとおりである) を示す。
(2) Formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, Ac represents an acetyl group, R represents a lower alkyl group.) and the formula: ▲There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, Bn is a benzyl group and Phth is a phthaloyl group.) A compound represented by the following formula is reacted in the presence of a glycosylation catalyst, and if necessary, deacetylation, debenzylation, dephthaloylation, and acetylation are performed. A method for producing a complex polysaccharide represented by the following general formula. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ In the formula, R is a hydrogen atom or a lower alkyl group, R^1 is a hydrogen atom or an acetyl group, R^2 is a hydrogen atom or a benzyl group, R^3 is a hydrogen atom, R^ 4 is an acetyl group, or R^3 and R^4 jointly represent a phthaloyl group, and Y is a hydrogen atom or ▲A numerical formula, a chemical formula, a table, etc.▼ (In the formula, R and R^1 are as defined above. ).
JP18623986A 1986-08-08 1986-08-08 Complex polysaccharide and method for producing the same Expired - Lifetime JPH0717684B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18623986A JPH0717684B2 (en) 1986-08-08 1986-08-08 Complex polysaccharide and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18623986A JPH0717684B2 (en) 1986-08-08 1986-08-08 Complex polysaccharide and method for producing the same

Publications (2)

Publication Number Publication Date
JPS6341502A true JPS6341502A (en) 1988-02-22
JPH0717684B2 JPH0717684B2 (en) 1995-03-01

Family

ID=16184786

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18623986A Expired - Lifetime JPH0717684B2 (en) 1986-08-08 1986-08-08 Complex polysaccharide and method for producing the same

Country Status (1)

Country Link
JP (1) JPH0717684B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05126799A (en) * 1991-08-06 1993-05-21 Railway Technical Res Inst Deciding method for corrosion deterioration of three-layer metal wire
JPH0639353A (en) * 1992-01-27 1994-02-15 Takasago Denki Sangyo Kk Recovering machine for waste can
JP2007112810A (en) * 2006-12-26 2007-05-10 Seikagaku Kogyo Co Ltd Method for producing oligosaccharide
US7663361B2 (en) 2004-06-04 2010-02-16 Anritsu Industrial Solutions Co., Ltd. Metal detection device

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05126799A (en) * 1991-08-06 1993-05-21 Railway Technical Res Inst Deciding method for corrosion deterioration of three-layer metal wire
JPH0639353A (en) * 1992-01-27 1994-02-15 Takasago Denki Sangyo Kk Recovering machine for waste can
US7663361B2 (en) 2004-06-04 2010-02-16 Anritsu Industrial Solutions Co., Ltd. Metal detection device
JP2007112810A (en) * 2006-12-26 2007-05-10 Seikagaku Kogyo Co Ltd Method for producing oligosaccharide
JP4527104B2 (en) * 2006-12-26 2010-08-18 生化学工業株式会社 Method for producing oligosaccharide

Also Published As

Publication number Publication date
JPH0717684B2 (en) 1995-03-01

Similar Documents

Publication Publication Date Title
JPH0899989A (en) New glycolipid derivative and intermediate for its production
JPS6345293A (en) Sialosylceramide compound and production thereof
FI87573C (en) Process for the preparation of ganglioside-like compounds
JPS6341502A (en) Complex polysaccharide and production thereof
JPH02164893A (en) Novel beta-d-phenyltioxyrosed, preparation thereof,
JPH03120292A (en) Benzopyranone-beta-d-thioxyrocide and method of its preparation
EP0204344A2 (en) Sialosylcerebrosides and a preparation method thereof
US4447600A (en) N-Acetylneuraminic acid derivatives and the preparation thereof
JPH023797B2 (en)
AU641644B2 (en) A process for the preparation of etoposides
US4914195A (en) Process for preparing N-acetylneuraminic acid derivatives
JP3110474B2 (en) Oligosialyl-1,2-dialkyl-Sn-glycerol and synthetic intermediates thereof
AU604410B2 (en) Sialosyl glyceride and process for producing the same
CA1247608A (en) Derivatives having uronic acid structure; process for preparing the same and their biological uses
Watanabe et al. Proximately Assisted and Chemoselectively Cleavable Protecting Groups for Alcohols, 2-(2-(Arylmethyloxy) ethyl) benzoic Esters.
JPH04169597A (en) Purification of taurine-conjugation-type bile acid
CN110981933A (en) Method for efficiently synthesizing Aramchol
JP2906228B2 (en) Glucopyranose derivative salt
JPS61282390A (en) S-neuraminic acid derivative
JPS617284A (en) Selective deacetylation of acetyl derivative of saccharide
JPH064671B2 (en) Sialic acid derivative and method for producing the same
US4301276A (en) Synthesis of daunosamine hydrochloride and intermediates used in its preparation
JP2843695B2 (en) 10,11,12,13-Tetrahydro-desmycosin derivative, process for producing the same and use thereof as a medicament
JPS6335589A (en) X type neosphingolipid-relating compound and synthesis thereof
JP2753353B2 (en) Analogs of sialosyl cholesterol and method for producing the same